Form 4 for RCEL AVITA Medical, Inc.
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-18 · accession 0001193125-26-059552 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-19 | 2026-02-18 | RCEL | O'Toole David D | CFO | A - Grant | — | +105.5K | 137.1K | +333% | — |
| D | 2026-02-19 | 2026-02-18 | RCEL | O'Toole David D | CFO | A - Grant | $0.00 | +155.5K | 155.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-18 | A | A | 105,470 | — | 137,127 | D | — | — | (F1) Represents an award of restricted stock units (the "RSUs"), each RSU representing a contingent right to be issued one share of Common Stock of the Company (the "Common Stock"), that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments beginning on the date 12 months following the grant date of February 18, 2026. (F2) Includes unvested RSUs. |
| 2 | Derivative | Stock Options (Right to Buy) | 2026-02-18 | A | A | 155,510 | $0.00 | 155,510 | D | $4.31 · — to 2036-02-18 | 155,510 Common Stock | (F3) These Stock Options vest in three equal annual installments beginning the first anniversary of the grant date of February 18, 2026. |